Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses R Kamya

Showing results (11-20 of 546) with videos related to

Pageof 55
Sort By:
The American Journal of Tropical Medicine and Hygiene|November 25, 2003
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malariaDaniel Kyabayinze, Adithya Cattamanchi, Moses R Kamya, et al.
BMC Infectious Diseases|January 23, 2019
A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?Agnes N Kiragga, Frank Mubiru, Andrew D Kambugu, et al.
African Health Sciences|December 7, 2007
Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in UgandaDamalie Nakanjako, Daniel J Kyabayinze, Harriet Mayanja-Kizza, et al.
AIDS Research and Treatment|May 5, 2011
Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited SettingsBarbara Castelnuovo, Joseph Sempa, Kiragga N Agnes, et al.
AIDS (London, England)|January 25, 2012
Regional differences in predictive accuracy of WHO immunologic failure criteriaAgnes N Kiragga, Barbara Castelnuovo, Moses R Kamya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Increasing condom use without reducing HIV risk: results of a controlled community trial in UgandaPhoebe Kajubi, Moses R Kamya, Sarah Kamya, et al.
Implementation Science Communications|September 5, 2020
Sustainability of the streamlined ART (START-ART) implementation intervention strategy among ART-eligible adult patients in HIV clinics in public health centers in Uganda: a mixed methods studyRichard Katuramu, Moses R Kamya, Naome Sanyu, et al.
Malaria Journal|March 24, 2011
Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in UgandaDamalie Nakanjako, Agnes N Kiragga, Barbara Castelnuovo, et al.
The Journal of Infectious Diseases|October 11, 2003
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malariaGrant Dorsey, Jonathan Vlahos, Moses R Kamya, et al.
AIDS Research and Therapy|October 30, 2008
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significanceDamalie Nakanjako, Agnes Kiragga, Fowzia Ibrahim, et al.
Pageof 55

Showing results (11-20 of 546) with videos related to

Sort By:
Pageof 55
The American Journal of Tropical Medicine and Hygiene|November 25, 2003
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malariaDaniel Kyabayinze, Adithya Cattamanchi, Moses R Kamya, et al.
BMC Infectious Diseases|January 23, 2019
A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?Agnes N Kiragga, Frank Mubiru, Andrew D Kambugu, et al.
African Health Sciences|December 7, 2007
Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in UgandaDamalie Nakanjako, Daniel J Kyabayinze, Harriet Mayanja-Kizza, et al.
AIDS Research and Treatment|May 5, 2011
Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited SettingsBarbara Castelnuovo, Joseph Sempa, Kiragga N Agnes, et al.
AIDS (London, England)|January 25, 2012
Regional differences in predictive accuracy of WHO immunologic failure criteriaAgnes N Kiragga, Barbara Castelnuovo, Moses R Kamya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Increasing condom use without reducing HIV risk: results of a controlled community trial in UgandaPhoebe Kajubi, Moses R Kamya, Sarah Kamya, et al.
Implementation Science Communications|September 5, 2020
Sustainability of the streamlined ART (START-ART) implementation intervention strategy among ART-eligible adult patients in HIV clinics in public health centers in Uganda: a mixed methods studyRichard Katuramu, Moses R Kamya, Naome Sanyu, et al.
Malaria Journal|March 24, 2011
Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in UgandaDamalie Nakanjako, Agnes N Kiragga, Barbara Castelnuovo, et al.
The Journal of Infectious Diseases|October 11, 2003
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malariaGrant Dorsey, Jonathan Vlahos, Moses R Kamya, et al.
AIDS Research and Therapy|October 30, 2008
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significanceDamalie Nakanjako, Agnes Kiragga, Fowzia Ibrahim, et al.
Pageof 55